[3H]A-69024

A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors

Michael Kassiou, Ursula A. Scheffel, John L. Musachio, Marigo Stathis, Robert F Dannals

Research output: Contribution to journalArticle

Abstract

[3H]A-69024 has been prepared as a radioligand for studying the dopamine D1 receptor. [3H]A-69024 binds to rat striatal membranes with a KD = 14.3 ± 3.2 nM (mean ± SEM; n = 3) and Bmax = 63.5 ± 12.8 fmol/mg wet tissue (1.8 ± 0.3 pmol/mg protein). This ligand binds to only one site with a Hill coefficient close to unity. The in vivo biodistribution of [3H]A-69024 showed a high uptake in the striatum (5.9 %ID/g) at 5 min followed by clearance. As a measure of specificity, the striatum/cerebellar ratio reached a maximum of 6.7 at 30 min post-injection. Pre-treatment with the D1 antagonist R(+)SCH 23390 (1 mg/kg) reduced this ratio to unity. The dopamine antagonist (+)butaclamol and unlabeled A-69024 inhibited striatal uptake by 70 and 51%, respectively. Spiperone (D2/5-HT2A) and ketanserin (5-HT2A/5-HT2C) at doses of 1 mg/kg had no inhibitory effect on [3H]A-69024 uptake in the striatum; however, increased uptake of [3H]A-69024 by > 30% in the whole brain was observed. The selectivity and affinity of [3H]A-69024 suggests that this non-benzazepine radioligand may be useful for in vitro and in vivo studies of the dopamine D1 receptor.

Original languageEnglish (US)
JournalLife Sciences
Volume57
Issue number23
DOIs
StatePublished - Oct 27 1995

Fingerprint

A 69024
Dopamine D1 Receptors
Butaclamol
Ligands
Spiperone
Ketanserin
Dopamine Antagonists
Rats
Brain
Corpus Striatum
Tissue
Membranes
Scanning electron microscopy
Proteins
In Vitro Techniques

Keywords

  • dopamine D receptor
  • radioligand
  • tritium

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology

Cite this

[3H]A-69024 : A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors. / Kassiou, Michael; Scheffel, Ursula A.; Musachio, John L.; Stathis, Marigo; Dannals, Robert F.

In: Life Sciences, Vol. 57, No. 23, 27.10.1995.

Research output: Contribution to journalArticle

Kassiou, Michael ; Scheffel, Ursula A. ; Musachio, John L. ; Stathis, Marigo ; Dannals, Robert F. / [3H]A-69024 : A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors. In: Life Sciences. 1995 ; Vol. 57, No. 23.
@article{d6cde85e00de41e8978b84a01eedcb1b,
title = "[3H]A-69024: A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors",
abstract = "[3H]A-69024 has been prepared as a radioligand for studying the dopamine D1 receptor. [3H]A-69024 binds to rat striatal membranes with a KD = 14.3 ± 3.2 nM (mean ± SEM; n = 3) and Bmax = 63.5 ± 12.8 fmol/mg wet tissue (1.8 ± 0.3 pmol/mg protein). This ligand binds to only one site with a Hill coefficient close to unity. The in vivo biodistribution of [3H]A-69024 showed a high uptake in the striatum (5.9 {\%}ID/g) at 5 min followed by clearance. As a measure of specificity, the striatum/cerebellar ratio reached a maximum of 6.7 at 30 min post-injection. Pre-treatment with the D1 antagonist R(+)SCH 23390 (1 mg/kg) reduced this ratio to unity. The dopamine antagonist (+)butaclamol and unlabeled A-69024 inhibited striatal uptake by 70 and 51{\%}, respectively. Spiperone (D2/5-HT2A) and ketanserin (5-HT2A/5-HT2C) at doses of 1 mg/kg had no inhibitory effect on [3H]A-69024 uptake in the striatum; however, increased uptake of [3H]A-69024 by > 30{\%} in the whole brain was observed. The selectivity and affinity of [3H]A-69024 suggests that this non-benzazepine radioligand may be useful for in vitro and in vivo studies of the dopamine D1 receptor.",
keywords = "dopamine D receptor, radioligand, tritium",
author = "Michael Kassiou and Scheffel, {Ursula A.} and Musachio, {John L.} and Marigo Stathis and Dannals, {Robert F}",
year = "1995",
month = "10",
day = "27",
doi = "10.1016/0024-3205(95)02212-2",
language = "English (US)",
volume = "57",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - [3H]A-69024

T2 - A non-benzazepine ligand for in vitro and in vivo studies of dopamine d1 receptors

AU - Kassiou, Michael

AU - Scheffel, Ursula A.

AU - Musachio, John L.

AU - Stathis, Marigo

AU - Dannals, Robert F

PY - 1995/10/27

Y1 - 1995/10/27

N2 - [3H]A-69024 has been prepared as a radioligand for studying the dopamine D1 receptor. [3H]A-69024 binds to rat striatal membranes with a KD = 14.3 ± 3.2 nM (mean ± SEM; n = 3) and Bmax = 63.5 ± 12.8 fmol/mg wet tissue (1.8 ± 0.3 pmol/mg protein). This ligand binds to only one site with a Hill coefficient close to unity. The in vivo biodistribution of [3H]A-69024 showed a high uptake in the striatum (5.9 %ID/g) at 5 min followed by clearance. As a measure of specificity, the striatum/cerebellar ratio reached a maximum of 6.7 at 30 min post-injection. Pre-treatment with the D1 antagonist R(+)SCH 23390 (1 mg/kg) reduced this ratio to unity. The dopamine antagonist (+)butaclamol and unlabeled A-69024 inhibited striatal uptake by 70 and 51%, respectively. Spiperone (D2/5-HT2A) and ketanserin (5-HT2A/5-HT2C) at doses of 1 mg/kg had no inhibitory effect on [3H]A-69024 uptake in the striatum; however, increased uptake of [3H]A-69024 by > 30% in the whole brain was observed. The selectivity and affinity of [3H]A-69024 suggests that this non-benzazepine radioligand may be useful for in vitro and in vivo studies of the dopamine D1 receptor.

AB - [3H]A-69024 has been prepared as a radioligand for studying the dopamine D1 receptor. [3H]A-69024 binds to rat striatal membranes with a KD = 14.3 ± 3.2 nM (mean ± SEM; n = 3) and Bmax = 63.5 ± 12.8 fmol/mg wet tissue (1.8 ± 0.3 pmol/mg protein). This ligand binds to only one site with a Hill coefficient close to unity. The in vivo biodistribution of [3H]A-69024 showed a high uptake in the striatum (5.9 %ID/g) at 5 min followed by clearance. As a measure of specificity, the striatum/cerebellar ratio reached a maximum of 6.7 at 30 min post-injection. Pre-treatment with the D1 antagonist R(+)SCH 23390 (1 mg/kg) reduced this ratio to unity. The dopamine antagonist (+)butaclamol and unlabeled A-69024 inhibited striatal uptake by 70 and 51%, respectively. Spiperone (D2/5-HT2A) and ketanserin (5-HT2A/5-HT2C) at doses of 1 mg/kg had no inhibitory effect on [3H]A-69024 uptake in the striatum; however, increased uptake of [3H]A-69024 by > 30% in the whole brain was observed. The selectivity and affinity of [3H]A-69024 suggests that this non-benzazepine radioligand may be useful for in vitro and in vivo studies of the dopamine D1 receptor.

KW - dopamine D receptor

KW - radioligand

KW - tritium

UR - http://www.scopus.com/inward/record.url?scp=0028853813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028853813&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(95)02212-2

DO - 10.1016/0024-3205(95)02212-2

M3 - Article

VL - 57

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 23

ER -